Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: Role of the polyol pathway

Kidney International

Volumn 55, Issue 5, 1999, Pages 1970-1976

  Tsukushi, Saori ^a   Katsuzaki, Tomoyuki ^a   Aoyama, Isao ^a   Takayama, Fumio ^a   Miyazaki, Takashi ^a   Shimokata, Kaoru ^a   Niwa, Toshimitsu ^a  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Advanced glycation end products; Aldose reductase inhibitor; Diabetes mellitus; Erythrocytes; Hyperglycemia

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALDOSE REDUCTASE INHIBITOR; DEOXYGLUCOSE; IMIDAZOLE DERIVATIVE; POLYOL; SORBITOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; FEMALE; GLYCATION; HEMODIALYSIS; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; SPECTROFLUOROMETRY;

EID: 0032894831     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00418.x     Document Type: Article

References (38)

1. 1. KATO H, SHIN DB, HYASE F: 3-Deoxyglucosone crosslinks proteins under physiological conditions. Agric Biol Chem 51:2009-2011, 1987
2. 2. SHIN DB, HAYASE F, KATO H: Polymerization of protein caused by reaction with sugars and the formation of 3-deoxyglucosone under physiological conditions. Agric Biol Chem 52:1451-1458, 1988
3. 3. KONISHI Y, HAYASE F, KATO H: Novel imidazolones compound formed by the advanced Maillard reaction of 3-deoxyglucosone and arginine residues in proteins. Biosci Biotech Biochem 58:1953-1955, 1994
4. 4. HAYASE F, KONISHI Y, KATO H: Identification of the modified structure of arginine residues in proteins with 3-deoxyglucosone, a Maillard reaction intermediate. Biosci Biotech Biochem 59:1407-1411, 1995
5. 2-microglobulin is modified with N€-(carboxymethyl)lysine in dialysis-related amyloidosis. Kidney Int 50:1303-1309, 1996
6. 2-m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum. Kidney Int 49:861-867, 1996
7. 7. HAYASE F, NAGARAJ RH, MIYATA S, NJOROGE FG, MONNIER VM: Aging of proteins: Immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo. J Biol Chem 264:3758-3764, 1989
8. 8. DYER DG, BLACKLEDGE JA, THORPE SR, BAYNES JW: Formation of pentosidine during nonenzymatic browning of proteins by glucose. J Biol Chem 266:11654-11660, 1991
9. 9. NIWA T, TAKEDA N, YOSHIZUMI H, TATEMATSU A, OHARA M, TOMIYAMA S, NIIMURA K: Presence of 3-deoxyglucosone, a potent protein crosslinking intermediate of Maillard reaction, in diabetic serum. Biochem Biophys Res Commun 196:837-843, 1993
10. 10. NIWA T, TAKEDA N, MIYAZAKI T, YOSHIZUMI H, TATEMATSU A, MAEDA K, OHARA M, TOMIYAMA S, NIIMURA K: Elevated serum levels of 3-deoxyglucosone, a potent protein-cross-linking intermediate of the Maillard reaction, in uremic patients. Nephron 69:438-443, 1995
11. 11. KATO H, YAMAMOTO M, FUJIMAKI M: Mechanisms of browning degradation of D-fructose in special comparison with D-glucose-glycine reaction. Agric Biol Chem 33:939-948, 1969
12. 12. SZWELGOLD BS, KAPPLER F, BROWN TR: Identification of fructose-3-phosphate in the lens of diabetic rats. Science 247:451-454, 1990
13. 31P NMR spectroscopy. J Biol Chem 268:7763-7767, 1993
14. 14. LAL S, SZWERGOLD BS, TAYLOR AH, RANDALL WC, KAPPLER F, WELLS KK, BAYNES JW, BROWN TR: Metabolism of fructose-3-phosphate in the diabetic rat lens. Arch Biochem Biophys 318:191-199, 1995
15. 15. KONISHI Y, HAYASE F, KATO H: Novel imidazolones compound formed by the advanced Maillard reaction of 3-deoxyglucosone and arginine residues in proteins. Biosci Biotechnol Biochem 58:1953-1955, 1994
16. 16. HAYASE F, KONISHI Y, KATO H: Identification of the modified structure of arginine residues in proteins with 3-deoxyglucosone, a Maillard reaction intermediate. Biosci Biotechnol Biochem 59:1407-1411, 1995
17. 17. NIWA T, KATSUZAKI T, ISHIZAKI Y, HAYASE F, MIYAZAKI T, UEMATSU T, TATEMICHI N, TAKEI Y: Imidazolone, a novel advanced glycation end product, is present at high levels in kidneys of rats with streptozotocin-induced diabetes. FEBS Lett 407:297-302, 1997
18. 18. NIWA T, KATSUZAKI T, MIYAZAKI S, MOMOI T, AKIBA T, MIYAZAKI T, NOKURA K, HAYASA F, TATEMICHI N, TAKEI Y: Amyloid β2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis. Kidney Int 51:187-194, 1997
19. 19. NIWA T, KATSUZAKI T, MIYAZAKI S, MIYAZAKI T, ISHIZAKI Y, HAYASA F, TATEMICHI N, TAKEI Y: Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. J Clin Invest 99:1272-1280, 1997
20. 20. NIWA T, MIYAZAKI S, KATSUZAKI T, TATEMICHI N, TAKEI Y, MIYAZAKI T, MORITA T, HIRASAWA Y: Immunohistochemical detection of advanced glycation end products in dialysis-related amyloidosis. Kidney Int 48:771-778, 1995
21. 21. NIWA T, SATO M, KATSUZAKI T, TOMOO T, MIYAZAKI T, TATEMICHI N, TAKEI Y, KONDO T: Amyloid β2-microglobulin is modified with N€-(carboxymethyl)lysine in dialysis-related amyloidosis. Kidney Int 50:1303-1309, 1996
22. 22. KNECHT KJ, FEATHER MS, BAYNES JW: Detection of 3-deoxyfructose and 3-deoxyglucosone in human urine and plasma: Evidence for intermediate stages of the Maillard reaction in vivo. Arch Biochem Biophys 294:130-137, 1992
23. 23. HAMADA Y, NAKAMURA J, FUJISAWA H, YAGO H, NAKASHIMA E, KOH N, HOTTA N: Effect of glycemic control on plasma 3-deoxyglucosone levels in NIDDM patients. Diabetes Care 20:1466-1469, 1997
24. 24. LAL BS, KAPPLER F, WALKER M, ORCHARD TJ, BEISSWENGER PJ, SZWERGOLD BS, BROWN TR: Quantitation of 3-deoxyglucosone levels in human plasma. Arch Biochem Biophys 342:354-260, 1997
25. 25. FUJII E, IWASE H, KARAKASA H, YAJIMA Y, HOTTA K: The presence of 2-keto-3-deoxygluconic acid and oxoaldehyde dehydrogenase activity in human erythrocytes. Biochem Biophys Res Commun 210:852-857, 1995
26. 26. PETERSEN A, SZWERGOLD BS, KAPPLER F, WEINGARTEN M, BROWN TR: Identification of sorbitol 3-phosphate and fructose 3-phosphate in normal and diabetic human erythrocytes. J Biol Chem 265:17424-17427, 1990
27. 27. PETERSEN A, KAPPLER, F. SZWERGOLD BS, BROWN TR: Fructose metabolism in the erythrocyte, phosphorylation to fructose 3-phosphate. Biochem J 284:363-366, 1992
28. 28. KANAZU T, SHINODA M, NAKAYAMA T, DEYASHIKI Y, HARA A, SAWADA H: Aldehyde reductase is a major protein associated with 3-deoxyglucosone reductase activity in rat, pig and human livers. Biochem J 279:903-906, 1991
29. 29. OHTA M, TANIMOTO T, TANAKA A: Characterization of aldose reductase and aldehyde reductase from the medulla of rat kidney. Chem Pharm Bull 38:1639-1643, 1990
30. 30. LIANG ZQ, HAYASE F, KATO H: Aldose reductase from porcine liver metabolizing 3-deoxyglucosone, a Maillard reaction intermediate. Biosci Biotech Biochem 56:1074-1078, 1992
31. 31. TAKAHASHI M, FUJII J, TESHIMA T, SUZUKI K, SHIBA T, TANIGUCHI N: Identity of a major 3-deoxyglucosone-reducing enzyme with aldehyde reductase in rat liver established by amino acid sequencing and cDNA expression. Gene 127:249-253, 1993
32. 32. SATO K, NAKANISHI M, DEYASHIKI Y, HARA A, MATSUURA K, OHYA I: Purification and characterization of dimetric dihydrodiol dehydrogenase from dog liver. J Biochem 116:711-717, 1994
33. 33. KNECHT KJ, FEATHER MS, BAYNES JW: Detection of 3-deoxyfructose and 3-deoxyglucosone in human urine and plasma: Evidence for intermediate stages of the Maillard reaction in vivo. Arch Biochem Biophys 294:130-137, 1992
34. 34. VLASSARA H, BUCALA R, STRIKER L: Biology of disease. Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70:138-151, 1994
35. 35. CHIE W, ASAHI M, TAKAHASHI M, KANETO H, OKADO A, HIGASHIYAMA S, TANIGUCHI N: Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells. J Biol Chem 272:18453-18459, 1997
36. 36. OKADO A, KAWASAKI Y, HASUIKE Y, TAKAHASHI M, TESHIMA T, FUJII J, TANIGUCHI N: Induction of apoptotic cell death by methylglyoxal and 3-deoxyglucosone in macrophage-derived cell lines. Biochem Biophys Res Commun 225:219-224, 1996
37. 37. SHINODA T, HAYASE F, KATO H: Suppression of cell-cycle progression during the S phase of rat fibroblasts by 3-deoxyglucosone, a Maillard reaction intermediate. Biosci Biotech Biochem 58:2215-2219, 1994
38. 38. HOTTA N: New concepts and insights on pathogenesis and treatment of diabetic complications: Polyol pathway and its inhibition. Nagoya J Med Sci 60:89-100, 1997